BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20674335)

  • 1. Predictors of outcome and methodological issues in children with acute lymphoblastic leukaemia in El Salvador.
    Bonilla M; Gupta S; Vasquez R; Fuentes SL; deReyes G; Ribeiro R; Sung L
    Eur J Cancer; 2010 Dec; 46(18):3280-6. PubMed ID: 20674335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America.
    Gupta S; Antillon FA; Bonilla M; Fu L; Howard SC; Ribeiro RC; Sung L
    Cancer; 2011 Oct; 117(20):4788-95. PubMed ID: 21446043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador.
    Gupta S; Bonilla M; Fuentes SL; Caniza M; Howard SC; Barr R; Greenberg ML; Ribeiro R; Sung L
    Br J Cancer; 2009 Apr; 100(7):1026-31. PubMed ID: 19293804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia.
    Viana MB; Fernandes RA; de Carvalho RI; Murao M
    Int J Cancer Suppl; 1998; 11():56-61. PubMed ID: 9876480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB; Sather HN; Sensel MG; Trigg ME; Cherlow JM; Lukens JN; Wolff L; Uckun FM; Gaynon PS
    N Engl J Med; 1998 Jun; 338(23):1663-71. PubMed ID: 9614257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
    Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
    Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors.
    Gupta S; Bonilla M; Valverde P; Fu L; Howard SC; Ribeiro RC; Sung L
    Eur J Cancer; 2012 Jun; 48(9):1363-9. PubMed ID: 22082459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukaemia: the Wellington experience 1980-92.
    Bailey S; Lewis M
    N Z Med J; 1996 Jan; 109(1014):9-11. PubMed ID: 8628538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the urinary phosphorus content in the early stage following remission induction as a prognostic factor in acute lymphocytic leukemia in children].
    Nakajima M
    Hokkaido Igaku Zasshi; 2005 Jul; 80(4):419-25. PubMed ID: 16107057
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Schrøder H; Kjeldstad M; Boesen AM; Nielsen OJ; Schmidt KG; Johnsen HE; Gregersen H; Gustafsson G
    Ugeskr Laeger; 2006 Jun; 168(26-32):2554-8. PubMed ID: 16824410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant minimal residual disease in children with acute lymphoblastic leukemia.
    Mehta PA; Davies SM
    Pediatr Blood Cancer; 2007 Jan; 48(1):1-2. PubMed ID: 16642487
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
    Rumiantseva IuV; Karachunskiĭ AI; Aleĭnikova OV; Fechina LG; Shamardina AV; Litvinov DV; Ponomareva NI; Boĭchenko EG; Dudkin SA; Streneva OV; Kondratchik KL; Mansurova EG; Minkina LM; Lapotentova ES; Iniushkina EV; Iudina NB; Pavlova GP; Zhukovskaia EV; Khlebnikova OP; Lagoĭko SN; Basharova EV; Denisov RE; Zlobina VD; Banshchikova ES; Aslanian KS; Kondakova EV; Tselousova EV; Miakova NV; Turobova TV; Ryskal' OV; Chipsanova NF; Varfolomeeva SR; Rumiantsev AG
    Ter Arkh; 2010; 82(7):11-9. PubMed ID: 20853603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.